Data / Form D filings / Renthera Corp
Renthera Corp: Form D filing
Renthera Corp, a pharmaceuticals company in Austin, TX, filed a Form D with the SEC in 2025. The latest, on February 11, 2025, reports an offering of $25 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 800 BRAZOS ST., SUITE 703, Austin, TX, 78701
- Phone
- (929) 331-9107
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Texas
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2055270
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | New notice | $25,000,000 | $0 | $25,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daniel Lippman | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Feb 10, 2025 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Renthera Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.